eprintid: 10184149
rev_number: 6
eprint_status: archive
userid: 699
dir: disk0/10/18/41/49
datestamp: 2023-12-20 09:47:48
lastmod: 2023-12-20 09:47:48
status_changed: 2023-12-20 09:47:48
type: article
metadata_visibility: show
sword_depositor: 699
creators_name: Brown, Nicholas M
creators_name: Goodman, Anna L
creators_name: Horner, Carolyne
creators_name: Jenkins, Abi
creators_name: Brown, Erwin M
title: Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK
ispublished: pub
divisions: UCL
divisions: B02
divisions: D65
divisions: J38
note: © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
abstract: These evidence-based guidelines are an updated version of those issued in 2008. They have beenproduced following a review of the published literature (2007-18) pertaining to the treatment of infections caused by MRSA. The guidelines update, where appropriate, previous recommendations, takinginto account changes in the UK epidemiology of MRSA, ongoing national surveillance data and the efficacy of novel anti-staphylococcal agents licensed for use in the UK. Emerging therapies that have not been licensed for use in the UK at the time of the review have also been assessed.
date: 2021-03-01
date_type: published
publisher: OXFORD UNIV PRESS
official_url: https://doi.org/10.1093/jacamr/dlaa114
oa_status: green
full_text_type: pub
language: eng
primo: open
primo_central: open_green
verified: verified_manual
elements_id: 1875667
doi: 10.1093/jacamr/dlaa114
medium: Electronic-eCollection
pii: dlaa114
lyricists_name: Goodman, Anna
lyricists_id: ALGOO97
actors_name: Goodman, Anna
actors_id: ALGOO97
actors_role: owner
funding_acknowledgements: [BSAC]; [British Infection Association (BIA)]; [Healthcare Infection Society (HIS)]; [Infection Prevention Society (IPS)]
full_text_status: public
publication: JAC-Antimicrobial Resistance
volume: 3
number: 1
article_number: dlaa114
pages: 18
event_location: England
issn: 2632-1823
citation:        Brown, Nicholas M;    Goodman, Anna L;    Horner, Carolyne;    Jenkins, Abi;    Brown, Erwin M;      (2021)    Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK.                   JAC-Antimicrobial Resistance , 3  (1)    , Article dlaa114.  10.1093/jacamr/dlaa114 <https://doi.org/10.1093/jacamr%2Fdlaa114>.       Green open access   
 
document_url: https://discovery.ucl.ac.uk/id/eprint/10184149/1/Treatment%20of%20methicillin-resistant%20iStaphylococcus%20aureusi%20%28MRSA%29%20updated%20guidelines%20from%20the%20UK.pdf